By Professor Andrew David Carr

Journal articles

Carr A; Hudson J; Chuah J; Mallal S; Law M; Hoy J; Doong N; French M; Smith D; Cooper DA, 2001, 'HIV protease inhibitor substitution in patients with lipodystrophy: A randomized, controlled, open-label, multicentre study', AIDS, 15, pp. 1811 - 1822, http://dx.doi.org/10.1097/00002030-200109280-00010

Mooser V; Carr A, 2001, 'Antiretroviral therapy-associated hyperlipidaemia in HIV disease', Current Opinion in Lipidology, 12, pp. 313 - 319, http://dx.doi.org/10.1097/00041433-200106000-00011

Carr A; Morey A; Mallon P; Williams D; Thorburn DR, 2001, 'Fatal portal hypertension, liver failure, and mitochondrial dysfunction after HIV-1 nucleoside analogue-induced hepatitis and lactic acidaemia', Lancet, 357, pp. 1412 - 1414, http://dx.doi.org/10.1016/S0140-6736(00)04579-7

Blanco F; Carr A, 2001, 'Lipodystrophy syndrome: Diagnostic, clinic and therapeutic aspects', AIDS Reviews, 3, pp. 98 - 105

Carr A, 2001, 'Osteopenia in HIV infection.', AIDS Clinical Care, 13, pp. 71 - 78

Gan SK; Samaras K; Carr AD; Chisholm DJ, 2001, 'Anti-retroviral therapy, insulin resistance and lipodystrophy', Diabetes Obesity and Metabolism, pp. 67 - 71

Mallon PW; Cooper DA; Carr AD, 2001, 'HIV¿associated lipodystrophy.', HIV Medicine, 2, pp. 166 - 173

Zaunders J; Kaufmann GR; Cunningham PH; Smith DE; Grey PA; Suzuki K; Carr AD; Goh L; Cooper DA, 2001, 'Increased turnover of CCR5+ and redistribution of CCR5- CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection.', Journal of Infectious Diseases, 183, pp. 736 - 743

Carr AD; Miller J; Eisman JA; Cooper DA, 2001, 'Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy', AIDS, 15, pp. 703 - 709

Sabin CA; Olmscheid B; Moyle G; Carr A; Boyle B; Cohen C; Cooper D; Deeks S; Gulick T; Saag M, 2001, 'Selected Topics from the 8th Conference on Retroviruses and Opportunistic Infections, February 4–8, 2001, Chicago, Illinois', HIV Research & Clinical Practice, 2, pp. 366 - 370, http://dx.doi.org/10.1310/fpdy-dk6j-gltv-hc50

Carr AD; Baker D; Petoumenos K; Law MG; Smith D; Roth N; Anderson JA; Mallal SS, 2001, 'Time trends in antiretroviral treatment use in Australia', Venereology - the Interdisciplinary International Journal of Sexual Health, 14, pp. 162 - 168

Carr A; Yarchoan R, 2000, 'AIDS 2000. Clinical treatment: overview.', AIDS, 14 Suppl 3

Carr A, 2000, 'HIV protease inhibitor-related lipodystrophy syndrome', Clinical Infectious Diseases, 30, pp. S135 - S142, http://dx.doi.org/10.1086/313854

Miller J; Carr A; Smith D; Emery S; Law MG; Grey P; Cooper DA, 2000, 'Lipodystrophy following antiretroviral therapy of primary HIV infection', AIDS, 14, pp. 2406 - 2407, http://dx.doi.org/10.1097/00002030-200010200-00025

Carr A; Morey A; Cooper DA; Thorburn DR, 2000, 'Chronic liver failure and persistent mitochondrial dysfunction 2 years after nucleoside reverse transcriptase inhibitor (NRTI)-induced acute hepatitis and lactic acidemia', AIDS, 14, pp. S64 - S64, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000165192300211&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Carr A, 2000, 'Lipodystrophy syndrome: Developing a case definition', AIDS, 14, pp. S13 - S13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000165192300040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Carr A; Chuah J; Hudson J; French M; Hoy J; Law M; Sayer D; Emery S; Cooper DA, 2000, 'A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: The OzCombo1 study', AIDS, 14, pp. 1171 - 1180, http://dx.doi.org/10.1097/00002030-200006160-00014

Carr A; Miller J; Matthew L; Cooper DA, 2000, 'A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: Contribution to protease inhibitor-related lipodystrophy syndrome', AIDS, 14, pp. F25 - F32, http://dx.doi.org/10.1097/00002030-200002180-00001

Carr AD; Cooper DA, 2000, 'Adverse effects of antiretroviral therapy', Lancet, pp. 1423 - 1430

Rhodes DI; Ashton LJ; Solomon A; Carr AD; Cooper DA; Kaldor JM; Deacon N; For TAL-T, 2000, 'Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression', Journal of Virology, pp. 10581 - 10588

Sobanski MA; Barnes RA; Gray SJ; Carr AD; Kaczmarski EB; O'Rourke A; Murphy K; Cafferkey M; Ellis RW; Pidcock K; Hawtin P; Coakley WT, 2000, 'Measurement of Serum Antigen Concentration by Ultrasound-Enhanced Immunoassay and Correlation with Clinical Outcome in Meningococcal Disease', European Journal of Clinical Microbiology & Infectious Diseases, 19, pp. 260 - 266, http://dx.doi.org/10.1007/s100960050473

Irwin M; Carr A; Kaldor J, 2000, 'P37 The relationship between physical activity and HIV lipodystrophy syndrome in protease inhibitor recipients', HIV Medicine, 1, pp. 184 - 184, http://dx.doi.org/10.1046/j.1468-1293.2000.00024-121.x

Kaufmann GR; Zaunders J; Kelleher AD; Grey PA; Smith DE; Carr AD; Cooper DA, 2000, 'Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection', AIDS, 14, pp. 2543 - 2551

Baker R; Kotler D; Carr A; Torres RA, 1999, 'Altered body shape in HIV disease: A side effect of therapy?', AIDS Patient Care and Stds, 13, pp. 395 - 402, http://dx.doi.org/10.1089/apc.1999.13.395

Cooper DA; Penny R; Symonds G; Carr AD; Gerlach W; Sun L; Ely JA, 1999, 'A marker study of therapeutically transduced CD4+ peripheral blood lymphocytes in HIV discordant identical twins', Human Gene Therapy, 10, pp. 1401 - 1421

Wilkinson JG; Zaunders J; Carr AD; Cooper DA, 1999, 'CD8+ anti-human immunodeficiency virus suppressor activity (CASA) in response to antiretroviral therapy: loss of CASA is associated with loss of viremia', Journal of Infectious Diseases, 180, pp. 68 - 75

Vanhems P; Dassa C; Lambert J; Cooper DA; Perrin L; Vizzard J; Hirschel B; Kinloch-De Loes S; Carr AD; Allard R, 1999, 'Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection', Journal of acquired immune deficiency syndrome and human retrovirology, pp. 99 - 106

Carr AD; Samaras K; Thorisdottir A; Kaufmann GR; Chisholm DJ; Cooper DA, 1999, 'Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitis: a cohort study', The Lancet, pp. 2093 - 2099

Carr AD, 1999, 'HIV nucleoside analogues: new adverse effects on mitochondria', Lancet, pp. 1046 - 1047

Kaufmann GR; Cunningham PH; Zaunders J; Law MG; Vizzard J; Carr AD; Cooper DA, 1999, 'Impact of early HIV-1 RNA and T-lymphocyte dynamics during primary HIV-1 infection on the subsequent course of HIV-1 RNA levels and CD4+ T-lymphocyte counts in the first year of HIV-1 infection', Journal of acquired immune deficiency syndrome and human retrovirology, pp. 437 - 444

Freund J; Carr A; Samaras K; Law M; Chisholm DJ; Cooper DA; Griffiths MR; Majerovic Y; Noakes KA, 1999, 'Peripheral lipodystrophy measured by DEXA in patients receiving HIV protease inhibitors', Nuclear Medicine Communications, 20, pp. 390 - 390, http://dx.doi.org/10.1097/00006231-199904000-00104

Zaunders J; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright RH; Smith DE; Grey PA; Vizzard J; Carr AD; Cooper DA, 1999, 'Potent antiretroviral therapy of primary HIV-1 infection: partial normalisation of T lympho-cyte subsets and limited reduction of proviral DNA despite clearance of plasma viremia.', Journal of Infectious Diseases, 180, pp. 320 - 329

Carr AD, 1999, 'Protease inhibitor-induced lipodystrophy', AIDS Reviews, 1, pp. 29 - 36

Freund J; Griffiths MR; Majerovic Y; Noakes KA; Carr A; Cooper D, 1999, 'Skeletal display versus skeletal and soft tissue display analysis of whole-body composition', Nuclear Medicine Communications, 20, pp. 380 - 380, http://dx.doi.org/10.1097/00006231-199904000-00072

Bloch M; Carr AD; Vasak E; Cunningham PH; Smith DE, 1999, 'The use of human immunodeficiency virus post exposure prophylaxis after success-ful artificial insemination.', American Journal of Obstetrics and Gynecology, 181, pp. 760 - 761

Bloch M; Carr AD; Vasak E; Cunningham PH; Smith DD; Penny R, 1999, 'The use of human immunodeficiency virus postexposure prophylaxis following successful artificial insemination', American Journal of Obstetrics and Gynecology, 181, pp. 760 - 761

Carr A; Cooper DA, 1998, 'HIV and AIDS - Gap between biology and reality in AIDS', LANCET, 352, pp. 16 - 16, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000077742900016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Carr A; Cooper DA, 1998, 'Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor.', The New England journal of medicine, 339, pp. 1296

McAlinden MG; Magowan J; Wilson DJ; Insley G; Ferris P; Prendergast PJ; Rice J; Blayney AW; Dalstra M; Walsh M; McGloughlin T; Grace P; Colgan D; Bray D; McCormack BAO; Reilly R; Tancred D; Carr AJ; Leyland NS; Meenan J; Boyd A; Akay M; O'Dwyer B; Dunne NJ; Ryan K; Orr JF; Stungo B; Brennan EG; O'Hare NJ; Walsh MJ; Jordan MF; Rasheed AM; Kelly C; Kay E; Bouchier-Hayes DJ; Leahy A; Maher SA; O'Reilly D; Foley J; Gillan MA; Cole JS; Raghunathan S; O'Reilly MJG; Kenny T; Hourigan TF; Lyons GM; Cox SL; Kernohan WG; Fitzpatrick C; Dempsey GJ; Millar I; Kelly S; Charlwood AP; O'Brien S; Beverland DE; Kavanagh A; Neligan MF; McKenna J; Laracy P; Moran D; O'Beirne J; Nixon JR; Kenny P; Maher SA; Murphy LA; O'Rourke SK; O'Donoghue D; Gilchrist MD; Caulfield B; O'Brien B; Simms C; Lyons CG; Brady CL; Badran S; Clifford PM; Burden DJ; Taylor D; Hill R; Griffin S; De Barra E; Brook I; Reytil P; Blades M; O'Reilly JP; Masterson BF; Macauley D; Toner M; Walker J; Gillan J; Meenan J; Murphy H; McNamara P; Jones E; Kelly P; Rajah L, 1998, 'Royal academy of medicine in Ireland section of bioengineering - Proceedings of meeting held in dundalk, co. louth, in february 1998.', Irish Journal of Medical Science, 167, pp. 256 - 276, http://dx.doi.org/10.1007/BF02937426

Ryan BM; McKiernan S; Keeling PWN; Byrne PJ; Quill R; McCallion K; Mitchell RMS; Watson RGP; Collins JSA; Gardiner KR; Winter DC; O'Sullivan GC; Taylor CT; Fanning NF; Redmond HP; O'Donoghue DP; Baird AW; Harvey BJ; Brannigan AE; O'Connell PR; Regan MC; Fitzpatrick JM; Watson RWG; Lemass H; Ryan E; MacMathuna P; Crowe J; O'Keane JC; Goh J; Baird A; Maher L; Godson C; Brady HR; Petasis NA; Fokin VV; Barry MK; Grant DC; Sheahan K; O'Donoghue DP; Hyland JMP; Sheehan KM; Fitzgerald DJ; Murray FE; Heaney A; Collins JSA; Bamford KB; McFarland RJ; Tham TCK; McNamara D; Franelli S; Whelan H; Hamilton H; Beattie S; O'Morain C; Brennan EG; O'Hare N; McDermott R; Byrne PJ; McDougall NI; Collins JSA; Gieeson CM; Russell SEH; Sloan JM; Morrisey D; Murphy L; Kiely B; Fitzgerald G; Daly C; Shanahan F; Collins JK; Marteau P; Johnston SD; Coates C; Feighery C; O'Keeffe J; Whelan A; Lynch S; Weir DG; Abuzakouk M; Barnes L; O'Gorman N; McKenna M; Freaney R; Young M; Gaines S; Brady D; Drudy D; O'Farrelly C; Gilleece A; Fenelon L; McPartlin J, 1998, 'Irish society of gastroenterology - Proceedings of meeting held Friday 12th and Saturday 13th June, 1998', Irish Journal of Medical Science, 167, pp. 2 - 22, http://dx.doi.org/10.1007/BF02937203

Wurtz R; Carr A; Samaras K; Chisholm DJ; Cooper DA; Ho TTY; Chan KCW; Wong KH; Lee SS, 1998, 'Abnormal fat distribution and use of protease inhibitors (multiple letters) [7]', Lancet, 351, pp. 1735 - 1736, http://dx.doi.org/10.1016/s0140-6736(05)77774-6

Carr A; Samaras K; Burton S; Law M; Freund J; Chisholm DJ; Cooper DA, 1998, 'A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors', AIDS, 12, pp. F51 - F58, http://dx.doi.org/10.1097/00002030-199807000-00003

Collins S; Carr A; O'Keefe D, 1998, 'Evaluation of the effectiveness of a chronic pain management programme', Irish Journal of Psychology, 19, pp. 283 - 294, http://dx.doi.org/10.1080/03033910.1998.10558191

Carr AD; Samaras K; Chisholm DJ; Cooper DA, 1998, 'Abnormal fat distribution and use of protease inhibitors', Lancet, pp. 1736 - 1736

Kelleher AD; Roggensack M; Emery S; Carr AD; French MA; Cooper DA, 1998, 'Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens', Clinical and Experimental Immunology, 113, pp. 85 - 91

Carr AD; Cooper DA, 1998, 'Gap between biology and reality in AIDS', Lancet, pp. 16 - 16

Carr AD; Cooper DA, 1998, 'Lipodystrophy associated with an HIV-protease inhibitor', New England Journal of Medicine, pp. 1296 - 1296

Carr AD; Emery S; Lloyd AR; Hoy JF; Garsia R; French MA; Stewart GA; Fyfe G; Cooper DA, 1998, 'Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, milticenter study', Journal of Infectious Diseases, 178, pp. 992 - 999, http://jid.oxfordjournals.org/content/178/4/992.full.pdf+html

Carr AD; Samaras K; Chisholm DJ; Cooper DA, 1998, 'Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance', Lancet, pp. 1881 - 1883

Kaufmann GR; Cunningham PH; Kelleher AD; Zaunders J; Carr AD; Vizzard J; Law MG; Cooper DA; Catchpole BR; Baker D; Beveridge A; Bloch M; Byrne J; Doong N; Duncombe CJ; Finlayson R; Genn W; Kidd J; Mcfarlane R; Mcmurchie M; Mcnulty A; Pethebridge A; Quan D; Robertson M, 1998, 'Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection', Journal of Infectious Diseases, 178, pp. 1812 - 1815

Back to profile page